ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/17/3_Supplement/article-pYIA19-007.xml YIA19-007: Patient-Derived Tumor Organoids for Drug Discovery of High-Risk Hepatoblastoma 2019-03-01 https://harbor-dev.pubfactory.com/view/journals/jnccn/17/3_Supplement/article-pYIA19-002.xml YIA19-002: Axl-RTK Inhibition Modulates T Cell Functions and Synergizes With Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies 2019-03-01 https://harbor-dev.pubfactory.com/view/journals/jnccn/17/3_Supplement/article-pYIA19-003.xml YIA19-003: Size Matters: Larger Size CD19-Positive Extracellular Vesicles in Chronic Lymphocytic Leukemia (CLL) Inhibit Chimeric Antigen Receptor T-Cell Function 2019-03-01 https://harbor-dev.pubfactory.com/view/journals/jnccn/17/3_Supplement/article-pYIA19-005.xml YIA19-005: Immunotherapy for Prostate Cancer Combining CAR-Engineered T Cells with Targeted Immune Checkpoint Inhibition 2019-03-01 https://harbor-dev.pubfactory.com/view/journals/jnccn/17/3_Supplement/article-pYIA19-004.xml YIA19-004: Collateral Deletion of Glycolysis Genes Generates Selective Vulnerabilities to Inhibitors of Oxidative Phosphorylation 2019-03-01 https://harbor-dev.pubfactory.com/view/journals/jnccn/17/3_Supplement/article-pYIA19-001.xml YIA19-001: Mechanisms of Diagnostic Delay Among Black women With Endometrial Cancer (EC): Results from Qualitative Interviews and a National Analysis of Healthcare Data 2019-03-01 https://harbor-dev.pubfactory.com/view/journals/jnccn/17/3_Supplement/article-pYIA19-006.xml YIA19-006: Preclinical Pediatric MATCH 2019-03-01